Assembly Biosciences, Inc. (ASMB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1150630,
    "name": "Assembly Biosciences, Inc.",
    "stock_name": "Assembly Biosciences, Inc.",
    "full_name": "Assembly Biosciences, Inc.",
    "name_url": "stocks-analysis/assembly-biosciences-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "32.35",
    "chg": -0.23,
    "chgp": "-0.71%",
    "dir": -1,
    "prev_price": "32.58",
    "mcapval": "362.86",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US0453961080",
    "curr_date": "Dec 18",
    "curr_time": "",
    "bse_nse_vol": "358.88 k",
    "exc_status": "Active",
    "traded_date": "Dec 18, 2025",
    "traded_date_str": "2025 12 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/assembly-biosciences-inc-1150630-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Assembly Biosciences, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-assembly-biosciences-inc-technically-bullish-or-bearish-3547467",
        "imagepath": "",
        "date": "2025-09-20 19:55:55",
        "description": "As of 12 September 2025, the technical trend for Assembly Biosciences, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators from the MACD, which is bullish on a weekly basis, and the moving averages, which are also bullish daily. Bollinger Bands show a bullish trend weekly and mildly bullish monthly. The KST is bullish for both weekly and monthly periods. However, the Dow Theory indicates a mildly bearish stance weekly, and the OBV shows a mildly bearish trend weekly as well.\n\nIn terms of performance, the stock has a year-to-date return of 41.13%, significantly outperforming the S&P 500's return of 12.22%, but it has underperformed over longer periods, particularly in the 3-year and 5-year comparisons. Overall, the current technical stance is bullish, driven primarily by the MACD and moving averages...."
      },
      {
        "title": "Is Assembly Biosciences, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-assembly-biosciences-inc-overvalued-or-undervalued-3543825",
        "imagepath": "",
        "date": "2025-09-20 18:29:44",
        "description": "As of 28 March 2024, the valuation grade for Assembly Biosciences, Inc. has moved from does not qualify to risky, indicating an increased perception of risk associated with the stock. The company appears to be overvalued, given its high Price to Book Value of 4.57 and negative EV to EBIT and EV to EBITDA ratios of -0.75, which suggest that the market may be pricing in expectations that are not supported by current financial performance.\n\nIn comparison to its peers, Assembly Biosciences has a P/E ratio of -9.31, while Societal CDMO, Inc. shows a more negative P/E of -10.74, and Outlook Therapeutics, Inc. has a P/E of -0.58. The negative ROE of -147.12% further underscores the challenges the company faces in generating returns. Notably, while the stock has outperformed the S&P 500 on a year-to-date basis with a return of 41.13% compared to 12.22%, its longer-term performance reflects significant underperforma..."
      }
    ],
    "total": 7,
    "sid": "1150630",
    "stock_news_url": "https://www.marketsmojo.com/news/assembly-biosciences-inc-1150630"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Assembly Biosciences, Inc. technically bullish or bearish?

2025-09-20 19:55:55

As of 12 September 2025, the technical trend for Assembly Biosciences, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators from the MACD, which is bullish on a weekly basis, and the moving averages, which are also bullish daily. Bollinger Bands show a bullish trend weekly and mildly bullish monthly. The KST is bullish for both weekly and monthly periods. However, the Dow Theory indicates a mildly bearish stance weekly, and the OBV shows a mildly bearish trend weekly as well. In terms of performance, the stock has a year-to-date return of 41.13%, significantly outperforming the S&P 500's return of 12.22%, but it has underperformed over longer periods, particularly in the 3-year and 5-year comparisons. Overall, the current technical stance is bullish, driven primarily by the MACD and moving averages....

Is Assembly Biosciences, Inc. overvalued or undervalued?

2025-09-20 18:29:44

As of 28 March 2024, the valuation grade for Assembly Biosciences, Inc. has moved from does not qualify to risky, indicating an increased perception of risk associated with the stock. The company appears to be overvalued, given its high Price to Book Value of 4.57 and negative EV to EBIT and EV to EBITDA ratios of -0.75, which suggest that the market may be pricing in expectations that are not supported by current financial performance. In comparison to its peers, Assembly Biosciences has a P/E ratio of -9.31, while Societal CDMO, Inc. shows a more negative P/E of -10.74, and Outlook Therapeutics, Inc. has a P/E of -0.58. The negative ROE of -147.12% further underscores the challenges the company faces in generating returns. Notably, while the stock has outperformed the S&P 500 on a year-to-date basis with a return of 41.13% compared to 12.22%, its longer-term performance reflects significant underperforma...

View All News